STEM Times of Connecticut: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM Times of Connecticut.

Press releases published on October 7, 2026

6 hours ago

Aptean Launches Ascent, an Outcome-Based AI Partnership Built on Measurable Business Results

Indeterminate GlobeNewswire

6 hours ago

Aptean lance Ascent, un partenariat d’IA axé sur les résultats et fondé sur une performance métier mesurable

Indeterminate GlobeNewswire

6 hours ago

Aptean lanceert Ascent, een AI-partnerschap op basis van meetbare bedrijfsresultaten

Indeterminate GlobeNewswire

6 hours ago

Kyverna Therapeutics to Present Positive Data in Stiff Person Syndrome and Progressive Multiple Sclerosis at MSToronto2026

Indeterminate GlobeNewswire

6 hours ago

Jasper Therapeutics Announces Commencement of an Offer to Purchase Outstanding Warrants

Indeterminate GlobeNewswire

6 hours ago

Atsena Presents Positive Preliminary Safety and Efficacy Results from Parts A and B of the Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis

Indeterminate GlobeNewswire

6 hours ago

Healthrise Identifies Key Factors for a Faster, More Efficient EHR Go-Live

Indeterminate GlobeNewswire

6 hours ago

Cerevance Announces Positive Phase 3 ARISE Results: Once-daily Oral Solengepras Meets Primary Endpoint and Demonstrates Motor and Non-motor Benefits in Parkinson's Disease

Indeterminate GlobeNewswire

6 hours ago

Crane NXT Appoints Jeong H. Kim to Board of Directors

Indeterminate GlobeNewswire

6 hours ago

BrewDog Rallies Beer Lovers Across the UK to Choose Craft

Indeterminate GlobeNewswire

6 hours ago

Caspian Therapeutics and Kura Oncology to Host Investor Webcast Highlighting Caspian’s Launch and KO-7246 Preclinical Data in Diabetes

Indeterminate GlobeNewswire

7 hours ago

CHARM Therapeutics announces first patient dosed and first cohort fully enrolled in its Phase I/II clinical trial of CHM-029 for Acute Myeloid Leukemia

Indeterminate GlobeNewswire

7 hours ago

Lantronix CEO to Meet with Investors and Defense Customers at AUSA 2026

Indeterminate GlobeNewswire

7 hours ago

Kane Biotech to Present Clinical Data and Showcase revyve® Product Line at SAWC Fall 2026

Indeterminate GlobeNewswire

7 hours ago

Zenas BioPharma Announces Upcoming Presentations of Orelabrutinib Data in Relapsing Remitting Multiple Sclerosis, Clinical Trial Designs in Progressive Multiple Sclerosis and Other Multiple Sclerosis Portfolio Data at MSToronto2026

Indeterminate GlobeNewswire

7 hours ago

VERAXA Biotech Provides Overview on Implementation of FDA-Aligned Human-Relevant Models into R&D Strategy

Indeterminate GlobeNewswire

7 hours ago

Matchpoint Therapeutics Announces $150 Million Series B Financing to Advance Pipeline of First-In-Class Oral Small Molecules for Autoimmune and Inflammatory Diseases

Indeterminate GlobeNewswire

7 hours ago

Atavistik Bio to Present at the Cure HHT 16th International Scientific Conference

Indeterminate GlobeNewswire

7 hours ago

Arvinas Shares Novel Oculomotor and Biomarker Data from Phase 1 Clinical Trial of ARV-102 in Patients with Parkinson’s Disease

Indeterminate GlobeNewswire

7 hours ago

BillionToOne’s Tissue-Free Northstar Response® Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds

Indeterminate GlobeNewswire